MODI IN, Israel (AP) _ Vascular Biogenics Ltd. (VBLT) on Wednesday reported a loss of $4.2 million in its first quarter.
The Modi In, Israel-based company said it had a loss of 12 cents per share.
The gene therapy biotech company posted revenue of $219,000 in the period.
The company's shares closed at $1.24. A year ago, they were trading at $2.20.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VBLT at https://www.zacks.com/ap/VBLT